| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 05/12/1992 | US5112950 Factor viii analog, preparation process, and pharmaceutical composition containing it |
| 05/12/1992 | US5112949 Method of and apparatus for separating proteins |
| 05/12/1992 | US5112615 Soluble hirudin conjugates |
| 05/10/1992 | WO1992008804A1 Erythrocytes and thrombo-erythrocytes as target specific agents |
| 05/10/1992 | CA2095925A1 Erythrocytes and thrombo-erythrocytes as target specific abents |
| 05/08/1992 | CA2054569A1 Process for preparing benzo¬c|phenanthridinium derivatives, and novel compounds prepared by said process |
| 05/06/1992 | EP0484017A2 Endothelin precursors, genes and receptors |
| 05/06/1992 | EP0483733A1 Process for preparing epoxy-heparides, the products obtained and pharmaceutical compositions containing them |
| 05/06/1992 | EP0483667A2 Cyclic imino derivatives, process for their preparation and drugs containing them |
| 05/05/1992 | US5110925 Cardiotonic agents |
| 05/05/1992 | US5110918 Process for preparing EDTA-free heparins, heparin fractions and fragments |
| 05/05/1992 | US5110909 Both covalent and ionic bonding with ligand attached to polymer |
| 05/05/1992 | CA1300313C2 Amino acid derivatives |
| 05/05/1992 | CA1300151C 1,3-dihydro-6-¬1-cyano-1-isopropyl-n-phenethyl-n-methyl- aminoalkyl|-7-hydroxy-furo-(3,4-c)-pyridine derivatives |
| 05/05/1992 | CA1300008C Acid lyophilised pharmaceutical formulation of tissue plasminogen activator |
| 05/03/1992 | WO1992007870A1 Platelet aggregation inhibitors |
| 05/03/1992 | WO1992007558A1 1,4-bis-(amino-hydroxyalkylamino)-anthraquinones for inhibiting protein kinase c |
| 05/03/1992 | CA2092315A1 Platelet aggregation inhibitors |
| 05/03/1992 | CA2072884A1 1,4-bis-(amino-hydroxyalkylamino)-anthraquinones for inhibiting protein kinase c |
| 05/02/1992 | WO1992007585A1 The use of antibodies to tnf or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor |
| 05/02/1992 | CA2094154A1 Use of antibodies to tnf or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor |
| 04/30/1992 | WO1992007005A1 Platelet adhesion inhibitor |
| 04/30/1992 | WO1992006975A1 1'-aminospiro[isoquinoline-4(1h),3'-pyrrolidine]-1,2',3,5'(2h)-tetrones and analogs thereof useful as aldose reductase inhibitors |
| 04/30/1992 | WO1992006974A1 Alkylidene analogs of 1'-aminospiro[isoquinoline-4(1h),3'-pyrrolidine]-1,2',3,5'(2h)-tetrones useful as aldose reductase inhibitors |
| 04/30/1992 | WO1992006711A1 Blood coagulation protein antagonists and uses therefor |
| 04/30/1992 | CA2094372A1 Blood coagulation protein antagonists and uses therefor |
| 04/30/1992 | CA2054347A1 Process for preparing epoxy-heparides, the products obtained and pharmaceutical compositions containing them |
| 04/29/1992 | EP0482966A2 Stabilised derivatives of fragments of hirudin, their preparation and pharmaceutical preparations |
| 04/29/1992 | EP0482771A2 Heterocyclic acids |
| 04/29/1992 | EP0482208A1 Pyridazinone derivative |
| 04/29/1992 | EP0482144A1 Method for the recombinant production of hiridins and hirudin-like polypeptides |
| 04/28/1992 | US5109113 Membrane anchor fusion polypeptides |
| 04/28/1992 | US5109021 Prostaglandin analogues, process for their preparation and pharmaceutical compositions containing them |
| 04/28/1992 | US5108901 Tissue plasminogen activator having zymogenic or fibrin specific properties |
| 04/28/1992 | US5108754 Orthomolecular method of treating sickle cell disease |
| 04/28/1992 | CA1299578C Indane derivatives, their preparation process and novel intermediates thus obtained, their application as medicines and compositions containing same |
| 04/22/1992 | EP0481522A1 Novel mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
| 04/22/1992 | EP0480925A1 Fluorocarbon emulsions having saturated phospholipid emulsifiers. |
| 04/22/1992 | CN1060472A Tripeptide antithrombotic agents |
| 04/22/1992 | CN1060464A 4,5-substituted pyridine-2-carboxylic acids, process for preparation thereof and use thereof as pharmaceuticals |
| 04/21/1992 | US5106954 Erythropoietin (epo) peptides |
| 04/21/1992 | US5106832 Method for treating renal diseases |
| 04/21/1992 | US5106610 Method for determining the diuretic potency of candidate drugs as inhibitors of the antidiuretic hormone-elicited water channel |
| 04/21/1992 | CA1299126C Hirudin-pa and its derivatives |
| 04/20/1992 | CA2028031A1 Aryloxy alcoyl benzens, process for the preparation thereof and pharmaceutical compositions comprizing them |
| 04/18/1992 | WO1992006999A1 Therapeutic fragments of von willebrand factor |
| 04/18/1992 | CA2094259A1 Therapeutic fragments of von willebrand factor |
| 04/18/1992 | CA2053650A1 Endothelin precursors, genes and receptors |
| 04/16/1992 | WO1992006203A1 MUTANTS OF tPA WHICH ARE RESISTANT TO THEIR COGNATE SERPIN INHIBITOR |
| 04/15/1992 | EP0480906A2 Pharmaceutical preparation on basis of Lys-plasminogen |
| 04/15/1992 | EP0480651A1 Protein for inhibiting collagenstimulated platelet aggregation |
| 04/15/1992 | EP0480455A1 Optically active thienotriazolodiazepine compounds |
| 04/15/1992 | EP0480152A1 KS-505 derivatives |
| 04/15/1992 | EP0479948A1 Compositions and methods for the synthesis of natriuretic protein receptor b and methods of use |
| 04/15/1992 | EP0479892A1 Fused-ring aryl substituted imidazoles |
| 04/15/1992 | CN1060293A Fibrinogen receptor antagonists |
| 04/15/1992 | CN1060288A 5-benzyl substituted-benzimidazoline-2-thion derivatives and process for preparing the same |
| 04/14/1992 | US5104889 Thiazole derivatives |
| 04/14/1992 | US5104861 7-oxoprostacyclin derivatives which are useful as pharmaceuticals |
| 04/14/1992 | US5104653 Use of human interferon-beta for stimulation of erythropoiesis |
| 04/14/1992 | CA1298839C Process for the preparation of dextrorotatory 3-)3-pyridyl-)1h,-pyrrolo(1,2-c) thiazole-7-carboxylic acid |
| 04/14/1992 | CA1298836C Imidazoquinoline antithrombogenic cardiotonic agents |
| 04/14/1992 | CA1298833C Glycerol derivatives, their production and use |
| 04/14/1992 | CA1298783C Acellular red blood cell substitute |
| 04/13/1992 | WO1992006712A1 Megakaryocyte maturation factors |
| 04/13/1992 | CA2071479A1 Megakaryocyte maturation factors |
| 04/13/1992 | CA2053123A1 Optically active thienotriazolodiazepine compounds |
| 04/12/1992 | WO1992006998A1 Cyclopeptides, a method of preparing them, and their use as drugs |
| 04/12/1992 | CA2089747A1 Cyclopeptides, a method of preparing them, and their use as drugs |
| 04/10/1992 | CA2052486A1 Protein for inhibiting collagen-stimulated platelet aggregation |
| 04/09/1992 | DE4031731A1 Protein aus hirudo medicinalis Protein from hirudo medicinalis |
| 04/08/1992 | EP0479489A2 Tripeptide antithrombotic agents |
| 04/08/1992 | EP0479481A2 Fibrinogen receptor antagonists |
| 04/08/1992 | EP0479178A2 4- or 5-substituted pyridine-2-carboxylic acids, process for their preparation and their use as medicaments |
| 04/08/1992 | EP0268581B1 Prostacyclines, their analogues or prostaglandines and thromboxane antagonists for the treatment of thrombotic and thrombo-embolic illnesses |
| 04/08/1992 | CN1060112A Human c3b/c4b receptor (cr1) |
| 04/08/1992 | CN1060092A Calcium uptake inhibitors |
| 04/08/1992 | CN1016175B Preparation for imidazoquinoline antithombogehic cardiotonic agents |
| 04/07/1992 | WO1992006118A1 Protein produced from hirudo medicinalis |
| 04/07/1992 | US5102995 Dna encoding modified heparin cofactor ii |
| 04/07/1992 | US5102888 Quinoline type mevalonolactones useful for treating hyperlipidemia and related diseases |
| 04/07/1992 | US5102886 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones and analogs thereof useful as aldose reductase inhibitors |
| 04/07/1992 | US5102878 Treating psychological, bone, cardiovascular, blood disorders |
| 04/07/1992 | US5102869 Urogenital disorders |
| 04/07/1992 | US5102652 Biodegradable coated paramagnetic colloids and mannitol; storage stability; treating anemia |
| 04/07/1992 | CA2093432A1 Protein from hirudo medicinalis |
| 04/07/1992 | CA1298580C ¬¬¬(3-pyridinyl)methylen|amino|oxy|alkanoic acids and esters |
| 04/05/1992 | WO1992005748A1 Soluble hirudin conjugates |
| 04/05/1992 | CA2092540A1 Soluble hirudin conjugates |
| 04/05/1992 | CA2052294A1 Heterocyclic acids |
| 04/04/1992 | WO1992006088A1 Indole derivatives as antiallergy and antiinflammatory agents |
| 04/04/1992 | CA2092404A1 Indole derivatives as antiallergy and antiinflammatory agents |
| 04/02/1992 | CA2052509A1 4- or 5- substituted pyridine-2-carboxylic acids, a process for the preparation thereof and the use thereof as pharmaceuticals |
| 04/01/1992 | EP0478363A2 Novel sulfonamide fibrinogen receptor antagonists |
| 04/01/1992 | EP0478362A2 Fibrinogen receptor antagonists |
| 04/01/1992 | EP0478328A1 Novel fibrinogen receptor antagonists |
| 04/01/1992 | EP0478101A2 Therapeutic use of peptides having thrombospondin-like activity |
| 04/01/1992 | EP0477971A2 Human CNP gene and precursor protein |
| 04/01/1992 | EP0477269A1 Pharmaceutical compositions and methods of treatment using alzheimer's amyloid polypeptides |
| 03/31/1992 | US5101048 Antithrombotics |